Clinical Trials Directory

Trials / Completed

CompletedNCT02251886

Moxibustion in a Randomized Trial for Version of Breech Position From Week 32

Moxibustion for Version of Singleton Breech Position Before Term

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Herning Hospital · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Moxibustion was tested for version of a breech position in singleton pregnancies. The women were randomized in week 32 to either moxibustion on acupuncture point Bl 67 daily in 15-20 minutes or no moxibustion. In week 36-37 the fetal position was checked and external cephalic version was offered for those still in breech position. The randomization was stratified for primigravida and multiparae separately. The randomization was made with a random number even and odd numbers indicating moxibustion or not. The randomization result was hidden in a sealed, non-transparent envelope on the obstetrical department and drawn when the woman gave informed consent to the study.

Detailed description

Moxibustion was tested for version of a breech position in singleton pregnancies. The women were randomized in week 32 to either moxibustion on acupuncture point Bl 67 daily in 15-20 minutes or no moxibustion. In week 36-37 the fetal position was checked and external cephalic version was offered for those still in breech position. The randomization was stratified for primigravida and multiparae separately. The randomization was made with a random number even and odd numbers indicating moxibustion or not. The randomization result was hidden in a sealed, non-transparent envelope on the obstetrical department and drawn when the woman gave informed consent to the study. Sample size calculation gave 45 women in each group, based on alfa 0.05 and beta 20 under condition of a 30 % effect of moxibustion vs. 20 % of spontaneous version in the control group in primiparae and 60 % in multiparae, respectively. Thus, 4 times 45 women in each group were sought. Only women who had performed three treatments were judged under the principle of intention to treat. Exclusion criteria at inclusion in week 32 was bleeding in 2nd and 3rd trimester, placenta insufficiency, cervical shortening, premature rupture of membranes, preeclampsia, elevated blood pressure, pelvic insufficiency, low placental position, uterine malformations, former uterine corrective surgery and known fetal morbidity

Conditions

Interventions

TypeNameDescription
OTHERMoxibustion in primiparaeNumber of primiparae participants with Version of Fetal Breech Position to Cephalic Position up to 4 weeks after treatment
OTHERMoxibustion in multiparaeNumber of multiparae participants with Version of Fetal Breech Position to Cephalic Position up to 4 weeks after treatment"

Timeline

Start date
2003-01-01
Primary completion
2011-01-01
Completion
2014-09-01
First posted
2014-09-29
Last updated
2017-03-03
Results posted
2016-12-01

Source: ClinicalTrials.gov record NCT02251886. Inclusion in this directory is not an endorsement.